What pharmacists need to know about oral antiviral treatments for COVID-19

0
The Therapeutic Goods Administration (TGA) has provisionally approved two oral antiviral treatments for COVID-19. Here’s what pharmacists need to know.

TGA approves estradiol patch substitutions

0
The TGA has told pharmacists, prescribers and patients to expect a shortage of Estradot (estradiol) HRT transdermal products until July 2021.

New Label 24 to help pharmacists reduce opioid risks

0
In line with TGA regulatory changes to enhance medicine safety, PSA has developed a cautionary advisory label that warns consumers about the risk of opioid overdose and dependence.

Alkyl nitrites: What are they, and why have they been rescheduled?

0
The Therapeutic Goods Administration (TGA) has reviewed their proposal to upschedule all alkyl nitrites to Schedule 9 (S9), but pharmacists will need to ensure...

Pharmacist prescribing of melatonin

0
Melatonin is a naturally occurring hormone responsible for regulating the body’s circadian rhythm. Here's when pharmacists can prescribe it.

Australia is in the grips of a cryptosporidiosis outbreak

0
Data from the National Notifiable Diseases Surveillance System reveals cases of cryptosporidiosis have skyrocketed in 2024.